481 related articles for article (PubMed ID: 19571281)
1. Preoperative staging of lung cancer with combined PET-CT.
Fischer B; Lassen U; Mortensen J; Larsen S; Loft A; Bertelsen A; Ravn J; Clementsen P; Høgholm A; Larsen K; Rasmussen T; Keiding S; Dirksen A; Gerke O; Skov B; Steffensen I; Hansen H; Vilmann P; Jacobsen G; Backer V; Maltbaek N; Pedersen J; Madsen H; Nielsen H; Højgaard L
N Engl J Med; 2009 Jul; 361(1):32-9. PubMed ID: 19571281
[TBL] [Abstract][Full Text] [Related]
2. Lung-cancer staging with PET-CT.
Bölükbas S; Baierlein SA; Schirren J
N Engl J Med; 2009 Oct; 361(16):1606; author reply 1608. PubMed ID: 19842245
[No Abstract] [Full Text] [Related]
3. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
4. Lung-cancer staging with PET-CT.
Hung JJ; Jeng WJ; Liu JS
N Engl J Med; 2009 Oct; 361(16):1606-7; author reply 1608. PubMed ID: 19842246
[No Abstract] [Full Text] [Related]
5. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer.
Cerfolio RJ; Ojha B; Bryant AS; Raghuveer V; Mountz JM; Bartolucci AA
Ann Thorac Surg; 2004 Sep; 78(3):1017-23; discussion 1017-23. PubMed ID: 15337041
[TBL] [Abstract][Full Text] [Related]
6. Lung-cancer staging with PET-CT.
Sharieff W
N Engl J Med; 2009 Oct; 361(16):1607; author reply 1608. PubMed ID: 19842248
[No Abstract] [Full Text] [Related]
7. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.
Yang W; Fu Z; Yu J; Yuan S; Zhang B; Li D; Xing L; Zhao D; Mu D; Sun X; Fang Y; Huang Y; Li W
Lung Cancer; 2008 Jul; 61(1):35-43. PubMed ID: 18177978
[TBL] [Abstract][Full Text] [Related]
8. Lung-cancer staging with PET-CT.
Bruzzi JF
N Engl J Med; 2009 Oct; 361(16):1606; author reply 1608. PubMed ID: 19828539
[No Abstract] [Full Text] [Related]
9. Lung-cancer staging with PET-CT.
Kloecker G; Civelek C; Janjua M
N Engl J Med; 2009 Oct; 361(16):1607; author reply 1608. PubMed ID: 19842247
[No Abstract] [Full Text] [Related]
10. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.
Lardinois D; Weder W; Hany TF; Kamel EM; Korom S; Seifert B; von Schulthess GK; Steinert HC
N Engl J Med; 2003 Jun; 348(25):2500-7. PubMed ID: 12815135
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers.
Liu BJ; Dong JC; Xu CQ; Zuo CT; Le JJ; Guan YH; Zhao J; Wu JF; Duan XH; Cao YX
Chin Med J (Engl); 2009 Aug; 122(15):1749-54. PubMed ID: 19781319
[TBL] [Abstract][Full Text] [Related]
12. A follow-up of integrated positron emission tomography/computed tomography after curative resection of non-small-cell lung cancer in asymptomatic patients.
Cho S; Lee EB
J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1447-51. PubMed ID: 20005529
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
[TBL] [Abstract][Full Text] [Related]
14. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.
Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929
[TBL] [Abstract][Full Text] [Related]
15. PET-CT in preoperative staging of lung cancer.
Fischer BM; Lassen U; Højgaard L
N Engl J Med; 2011 Mar; 364(10):980-1. PubMed ID: 21388332
[No Abstract] [Full Text] [Related]
16. Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study.
Kaira K; Oriuchi N; Otani Y; Shimizu K; Tanaka S; Imai H; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Dobashi K; Kanai Y; Endou H; Nakajima T; Endo K; Mori M
Clin Cancer Res; 2007 Nov; 13(21):6369-78. PubMed ID: 17975149
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of advantages of positron emission tomography over computed tomography for N-staging in lung cancer patients.
Ebihara A; Nomori H; Watanabe K; Ohtsuka T; Naruke T; Uno K; Kuwahira I; Eguchi K
Jpn J Clin Oncol; 2006 Nov; 36(11):694-8. PubMed ID: 17068084
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography-computed tomography for postoperative surveillance in non-small cell lung cancer.
Choi SH; Kim YT; Kim SK; Kang KW; Goo JM; Kang CH; Kim JH
Ann Thorac Surg; 2011 Nov; 92(5):1826-32; discussion 1832. PubMed ID: 22051278
[TBL] [Abstract][Full Text] [Related]
19. Staging of non-small-cell lung cancer with integrated PET and CT.
Miles KA
N Engl J Med; 2003 Sep; 349(12):1188-90; author reply 1188-90. PubMed ID: 14503542
[No Abstract] [Full Text] [Related]
20. Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer.
von Haag DW; Follette DM; Roberts PF; Shelton D; Segel LD; Taylor TM
J Surg Res; 2002 Apr; 103(2):160-4. PubMed ID: 11922730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]